J Taylor Hays Selected Research

Varenicline (Chantix)

1/2021	Frequently Reported Adverse Events With Smoking Cessation Medications: Post Hoc Analysis of a Randomized Trial.
1/2018	Varenicline for tobacco-dependence treatment in alcohol-dependent smokers: A randomized controlled trial.
8/2017	Combination Varenicline and Lorcaserin for Tobacco Dependence Treatment and Weight Gain Prevention in Overweight and Obese Smokers: A Pilot Study.
10/2016	Varenicline for Smoking Cessation in Light Smokers.
1/2016	Varenicline for smoking cessation: a narrative review of efficacy, adverse effects, use in at-risk populations, and adherence.
1/2014	Combination varenicline and bupropion SR for tobacco-dependence treatment in cigarette smokers: a randomized trial.
4/2012	Changes in health-related quality of life with smoking cessation treatment.
9/2011	A pilot study of the efficacy of varenicline for the treatment of smokeless tobacco users in Midwestern United States.
3/2011	Effects of varenicline on smoking cessation in patients with mild to moderate COPD: a randomized controlled trial.
1/2011	Varenicline for tobacco dependence treatment in recovering alcohol-dependent smokers: an open-label pilot study.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

J Taylor Hays Research Topics

Disease

21	Tobacco Use Disorder (Nicotine Dependence) 01/2018 - 01/2003
5	Nausea 01/2021 - 07/2006
3	Alcoholism (Alcohol Abuse) 01/2018 - 07/2005
3	Substance Withdrawal Syndrome (Withdrawal Symptoms) 01/2011 - 07/2006
2	Sleep Initiation and Maintenance Disorders (Insomnia) 01/2021 - 03/2011
2	Weight Gain 08/2017 - 12/2009
2	Chronic Obstructive Pulmonary Disease (COPD) 01/2015 - 03/2011
2	Chronic Disease (Chronic Diseases) 05/2011 - 03/2007
2	Seizures (Absence Seizure) 08/2003 - 01/2003
1	Fibromyalgia (Fibrositis) 06/2021
1	Disease Progression 01/2021
1	Unstable Angina 01/2018
1	Myocardial Infarction 01/2018
1	Stroke (Strokes) 01/2018
1	Peripheral Vascular Diseases (Peripheral Vascular Disease) 01/2018
1	Substance-Related Disorders (Drug Abuse) 08/2017
1	Overweight 08/2017
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2016
1	Asthma (Bronchial Asthma) 01/2015
1	Respiratory Tract Diseases (Respiratory Tract Disease) 01/2015
1	Pain (Aches) 03/2014
1	Chronic Pain 03/2014
1	Critical Illness (Critically Ill) 07/2011
1	Respiratory Tract Infections (Respiratory Tract Infection) 03/2011
1	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 01/2011
1	Mastodynia 09/2009
1	Breast Neoplasms (Breast Cancer) 09/2009
1	Thromboangiitis Obliterans (Buerger's Disease) 10/2008

Drug/Important Bio-Agent (IBA)

17	Varenicline (Chantix)FDA Link 01/2021 - 07/2006
7	Bupropion (Wellbutrin)FDA LinkGeneric 01/2021 - 01/2003
4	Nicotine FDA Link 01/2011 - 07/2006
3	SmokeIBA 01/2015 - 06/2005
2	Dopamine (Intropin)FDA LinkGeneric 04/2008 - 01/2003
1	Opioid Analgesics (Opioids)IBA 06/2021
1	omega-Chloroacetophenone (Mace)IBA 01/2018
1	lorcaserinIBA 08/2017
1	N 30IBA 03/2014
1	Methylphenidate (Ritalin)FDA LinkGeneric 01/2011
1	Pharmaceutical PreparationsIBA 12/2010
1	Gabapentin (Neurontin)FDA LinkGeneric 03/2010
1	sibutramine (Meridia)FDA Link 12/2009
1	Estrogens (Estrogen)FDA Link 09/2009
1	Hormones (Hormone)IBA 09/2009
1	AlkaloidsIBA 10/2008
1	nicotinic receptor alpha4beta2IBA 07/2006
1	CotinineIBA 07/2005
1	Antidepressive Agents (Antidepressants)IBA 01/2003

Therapy/Procedure

8	Drug Therapy (Chemotherapy) 06/2021 - 03/2007
7	Therapeutics 03/2014 - 01/2003
3	Tobacco Use Cessation Devices 01/2021 - 07/2005
1	Aftercare (After-Treatment) 01/2021
1	Nicotine Replacement Therapy 07/2011
1	Nebulizers and Vaporizers (Inhaler) 12/2010
1	Contraception (Birth Control) 09/2009
1	Hysterectomy 09/2009
1	Secondary Prevention 07/2005